MA Pharma Consulting ApS: Financial statements 2024
CVR: 44558076
Source: annual report 2024, Danish Business Authority
03/01/2024 – 31/12/2024
MA Pharma Consulting ApS (CVR 44558076) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 328,876 and a net result of DKK 69,511. Equity in the 2024 report amounted to DKK 109,511. The solvency ratio was 61.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 328,876
- Profit/Loss
- DKK 69,511
- Equity
- DKK 109,511
- Total Assets
- DKK 177,493
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of January 3, 2024, Marianne Holst is registered as adm. dir. of MA Pharma Consulting ApS.
As of January 3, 2024, Anne Kræmmer is registered as director of MA Pharma Consulting ApS.
MA Pharma Consulting ApS was founded on January 3, 2024.
About MA Pharma Consulting ApS
MA Pharma Consulting ApS was a Danish company of the type Anpartsselskab based in Nærum, founded in 2024. The company has been dissolved on 9 October 2025. The company was registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company has 2 employees (2025). In 2024, the company reported a gross profit of DKK 328,876 and a net result of DKK 69,511. Equity in the 2024 report amounted to DKK 109,511.